Inpatient Native Kidney Biopsies and Glomerular Disease: Utilization and Diagnostic Trends in the United States, 2006-2015.
Inpatient Native Kidney Biopsies and Glomerular Disease: Utilization and Diagnostic Trends in the United States, 2006-2015.
复制标题
DOI：
10.1016/j.xkme.2021.06.013
复制
发表时间：
2021-11
期刊：
影响因子：
3.9
通讯作者：
Walther CP
中科院分区：
文献类型：
--
作者：
Tran VV;Walther CP
肾脏活检是许多实质性肾脏疾病，特别是肾小球疾病确诊所必需的。它可以在住院或门诊环境中进行，也可以由肾科医生或放射科医生进行，近年来，实时图像引导已成为标准。1许多因素可能会影响与肾小球疾病相关的住院患者天然肾活检的使用，包括改变入院模式和标准，改变诊断趋势，甚至可能改变疾病模式。2我们调查了2006至2015年间美国成年人中与肾小球疾病相关的住院天然肾活检的趋势。我们使用了2006年1月1日至2015年9月30日的国家住院患者样本(NIS)数据。NIS是美国住院医疗保健的所有付款人数据库，包含每年700多万住院患者的数据。3它是社区医院出院的20%分层样本，允许对每年超过3500万次住院进行加权估计。3 NIS是公开可用的行政数据，使用不被认为是人类受试者研究，也不需要征得同意。我们确定了接受肾活检的18岁或18岁以上的患者(根据国际疾病分类，第9版，临床修改[ICD-9-CM]程序代码55.23确定)，并按年龄进行分类。我们排除了患有移植肾或肾肿瘤的人。
Kidney biopsy is necessary for definitive diagnosis of many parenchymal kidney diseases, particularly glomerular diseases. It can be performed in inpatient or outpatient settings and by nephrologists or radiologists, and in recent years, real-time image guidance has become standard. 1 Many factors may affect inpatient native kidney biopsy use related to glomerular disease, including changing admission patterns and criteria, changing diagnostic trends, and perhaps changing illness patterns. 2 We investigated trends in inpatient native kidney biopsies related to glomerular disease in US adults, 2006 to 2015.We used National Inpatient Sample (NIS) data from January 1, 2006, to September 30, 2015. The NIS is an all-payer database of inpatient health care in the United States, containing data from more than 7 million hospital stays each year. 3 It is a 20% stratified sample of discharges from community hospitals and allows weighted estimates on more than 35 million hospitalizations per year. 3 NIS is publicly available administrative data, use is not considered human subjects research, and consent was not required. We identified patients 18 years or older who underwent kidney biopsy (identified from International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] procedure code 55.23) and categorized by age. We excluded persons with a transplanted kidney or kidney tumor.
登录
查看更多内容
影响因子：
13.2
作者：
Luciano, Randy L.;Moeckel, Gilbert W.
通讯作者：
Moeckel, Gilbert W.
影响因子：
13.2
作者：
Hogan, Jonathan J.;Alexander, Mariam Priya;Leung, Nelson
通讯作者：
Leung, Nelson
影响因子：
6
作者：
Charu, Vivek;O'Shaughnessy, Michelle M.;Kambham, Neeraja
通讯作者：
Kambham, Neeraja
影响因子：
13.6
作者：
Srivastava, Anand;Palsson, Ragnar;Waikar, Sushrut S.
通讯作者：
Waikar, Sushrut S.